an almost certain rebound as the POG gets back on its trend line over the next few weeks and the irrational pessimism for goldies swings to optimism - managed to get more at 5.3
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
